Advertisement

Topics

OncoImmunin Incorporated Company Profile

17:30 EST 24th November 2017 | BioPortfolio

OncoImmunin, Inc. was founded by Dr. Akira Komoriya and Dr. Beverly Packard in 1994. The Company has been issued two U.S. patents on its proprietary design for protease inhibitors and fluorogenic substrates. The first PCT application has now entered into national phases in Japan and Europe and a second PCT was filed in 1998.

OncoImmunin, Inc. has designed, synthesized, validated, and patented a new class of protease substrates. Unique aspects of these molecules are: (1) incorporation of amino acid sequence information from both sides of protease cleavage sites (up to ten amino acid residues), thereby providing not only linear but three-dimensional specificity for proteases and (2) ability to cross intact cell membranes enabling measurement and inhibition of intracellular protease activities in living cells. Exploitation of elements of this latter point form the basis for OncoImmunin's patented design for the therapeutic delivery of peptide-based protease inhibitors as well as peptide-based inhibitors of other intracellular targets in sizes ranging up to twenty amino acids.

Location

207A Perry Parkway, Suite 6
Gaithersburg
MD
20877
United States of America

Contact

Phone: (301) 987-7881
Fax: (301) 987-7882
Email: info@phiphilux.com


News Articles [1 Associated News Articles listed on BioPortfolio]

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [38 Associated Companies listed on BioPortfolio]

OncoImmunin Incorporated

OncoImmunin, Inc. was founded by Dr. Akira Komoriya and Dr. Beverly Packard in 1994. The Company has been issued two U.S. patents on its proprietary design for protease inhibitors and fluorogenic subs...

OncoImmunin, Inc

OncoImmunin, Inc. was founded by Dr. Akira Komoriya and Dr. Beverly Packard in 1994. The Company has been issued three U.S. patents and one Australian patent on its proprietary design for protease inh...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

COOK BIOTECH INCORPORATED

COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...

More Information about "OncoImmunin Incorporated" on BioPortfolio

We have published hundreds of OncoImmunin Incorporated news stories on BioPortfolio along with dozens of OncoImmunin Incorporated Clinical Trials and PubMed Articles about OncoImmunin Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OncoImmunin Incorporated Companies in our database. You can also find out about relevant OncoImmunin Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record